$2.48
+0.07 (+2.90%)
Open$2.45
Previous Close$2.41
Day High$2.49
Day Low$2.43
52W High$7.33
52W Low$2.05
Volume—
Avg Volume281.7K
Market Cap39.90M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,411.3% upside
Current
$2.48
$2.48
Target
$37.48
$37.48
$21.76
$37.48 avg
$51.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.73M | 31.85M | 6.59M |
| Net Income | -46,398,927 | -64,165,694 | 1.64M |
| Profit Margin | -223.9% | -212.7% | 24.9% |
| EBITDA | -44,981,812 | -65,661,833 | 3.19M |
| Free Cash Flow | — | — | 1.30M |
| Rev Growth | -34.9% | -34.9% | +19.2% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |